Biomedical Structures LLC (BMS) — a Warwick, R.I.-based manufacturer of biomedical textiles for
medical devices and other clinical applications including cardiovascular, orthopedic, general
surgery and tissue engineering — has acquired Concordia Medical LLC — a provider of medical implant
technologies using biomaterials for tissue engineering and regenerative medicine, and a division of
Warwick-based engineered fiber producer Concordia Manufacturing LLC.
The acquisition includes Concordia Medical’s workforce, manufacturing facility and
technologies — including its nonwoven BIOFELT™ technology for tissue-engineering and regenerative
applications — and is expected to enhance BMS’s capabilities in the regenerative device area. Those
capabilities include expertise in braiding, knitting, nonwoven and weaving technologies as they
relate to medical textile design and manufacturing.
“With the acquisition of Concordia Medical, not only are we improving our biomedical textile
engineering expertise and medical device market penetration, but we are increasing our
manufacturing capacity to deliver on complex, sophisticated device applications at the volume our
customers require,” said John Gray, CEO and president, BMS. “The company is a terrific complement
to our advanced scientific expertise in medical textiles and will help bring our production
capabilities to the next level.”
Concordia Manufacturing will continue to own a share of Concordia Medical, and Concordia
Manufacturing CEO and President Randal Spencer will join BMS’s Board of Directors and will be
involved in the development of the combined company’s business.
March 22, 2011
